Published quarterly by the Research Collaboratory for Structural Bioinformatics Protein Data Bank

Message from RCSB PDB

Discovery and development of 210 new molecular entities approved by the US Food and Drug Administration from 2010–2016 was facilitated by 3D structural information generated by structural biologists worldwide and distributed on an open-access basis by the PDB. Nearly 6,000 PDB structures containing one of the known targets and/or a new drug are available; more than half were published and made available in the PDB archive more than 10 years before drug approval.

For the full analysis, see How Structural Biologists and the Protein Data Bank Contributed to Recent FDA New Drug Approvals in Structure ((2019) 27: 211-217 doi: 10.1016/j.str.2018.11.007).

Other PDB impact analyses are also available.

Snapshot: July 1, 2019
153,328 Released atomic coordinate entries
Molecule Type
142,183 Proteins, peptides, and viruses
3,348 Nucleic acids
7,767 Protein/nucleic acid complexes
30 Other
Experimental Technique
136,882 X-ray
12,667 NMR
3,353 Electron Microscopy
281 Hybrid
145 Other
Related Experimental Data Files
126,772 Structure factors
10,014 NMR restraints
3,766 Chemical shifts
3,413 3DEM map files